Apple Watch
The feature will be available via new iOS and watchOS updates, one year after the U.S. International Trade Commission banned Apple from selling its Series 9, Series 10 and Ultra 2 watches.
Maven Clinic introduces male fertility support tools, Scripta Insights announces a tool to locate cost-effective meds, and XRHealth launches a new platform.
The G7 continuous glucose monitoring system will have a 15.5-day wear time and last 15% longer than Dexcom G7, according to the company.
The Apple Health Study will use data collected from Apple devices to examine the relationship between physical and mental health and wellbeing.
Vitality Program participants receive other rewards and discounts, such as savings on life insurance premiums.
The Watch Series 10 feature is designed to detect moderate to severe sleep apnea, and AirPods Pro 2 provides OTC access to Apple's AI-powered hearing aid software.
The Series 10 will detect sleep apnea using breathing analysis algorithms. AirPods Pro 2 will automatically adjust to a user's needs according to findings from a hearing test taken using the iPhone and AirPods.
The feature allows users to obtain real-time CGM data on their Watch without an iPhone present.
The Agency has qualified Apple's atrial fibrillation history feature as a medical device development tool, allowing it to be used in clinical trials.
The company's Today Screen feature will show personalized health data in context of leading health risks, such as sedentary stress.